Twist Bioscience Corporation , a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of a new Human.
Twist Bioscience Co. (NASDAQ:TWST – Get Free Report) SVP Paula Green sold 600 shares of the company’s stock in a transaction on Wednesday, March 6th. The shares were sold at an average price of $37.43, for a total value of $22,458.00. Following the sale, the senior vice president now owns 92,850 shares of the company’s […]
Deutsche Bank AG increased its holdings in Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 4.8% in the third quarter, HoldingsChannel.com reports. The firm owned 51,208 shares of the company’s stock after buying an additional 2,368 shares during the quarter. Deutsche Bank AG’s holdings in Twist Bioscience were worth $1,037,000 at the end of the […]